Association of Lithium and Second-Generation Antipsychotics with Neurocognition in Youth with Bipolar Disorder.

Jiang, Xinyue; Mio, Megan; Dimick, Mikaela K; Zou, Yi; Sultan, Alysha A; Goldstein, Benjamin I

Jiang, Xinyue; Mio, Megan; Dimick, Mikaela K; Zou, Yi; Sultan, Alysha A; Goldstein, Benjamin I.

Afiliação

Jiang X; Centre for Youth Bipolar Disorder, Child and Youth Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Canada.
Mio M; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
Dimick MK; Centre for Youth Bipolar Disorder, Child and Youth Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Canada.
Zou Y; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
Sultan AA; Centre for Youth Bipolar Disorder, Child and Youth Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Canada.
Goldstein BI; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.

J Child Adolesc Psychopharmacol ; 32(1): 61-69, 2022 02.

Article em En | MEDLINE | ID: mdl-35085001

Assuntos

Antipsicóticos; Transtorno Bipolar; Adolescente; Adulto; Antimaníacos/efeitos adversos; Antipsicóticos/efeitos adversos; Transtorno Bipolar/complicações; Transtorno Bipolar/diagnóstico; Transtorno Bipolar/tratamento farmacológico; Humanos; Lítio/efeitos adversos; Testes Neuropsicológicos; Adulto Jovem

Palavras-chave

bipolar disorder; lithium; neurocognition; second-generation antipsychotics; youth

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Transtorno Bipolar Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: J Child Adolesc Psychopharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google